Resumo
Definição
História e exame físico
Outros fatores diagnósticos
- ansiedade
- agitação
- confusão
- tremores, espasmos musculares
- sudorese
- cefaleia
- taquicardia
- hipertonia/rigidez
- diaforese
- rubor
- pupilas dilatadas
- hipertermia
- mioclonia
- estimulação
Fatores de risco
- exposição a um medicamento serotoninérgico
- exposição a dois ou mais medicamentos serotoninérgicos
Investigações diagnósticas
Investigações a serem consideradas
- Hemograma completo
- creatina fosfoquinase
- eletrocardiograma (ECG)
- hemoculturas
- punção lombar
- tomografia computadorizada (TC) ou ressonância nuclear magnética (RNM) do crânio
Algoritmo de tratamento
Colaboradores
Autores
Geoffrey Isbister, BSc, MBBS, FACEM, MD
Clinical Toxicologist
Calvary Mater Newcastle
Associate Professor
University of Newcastle
Newcastle
Australia
Declarações
GI is an author of several references cited in this monograph.
Revisores
Laura Tormoehlen, MD, FAAN, FACMT
Neurologist and Medical Toxicologist
Associate Professor of Clinical Neurology and Emergency Medicine
Indiana University
Bloomington
IN
Declarações
LT has been compensated as an expert witness for cases involving serotonergic drugs.
Daniel E Brooks, MD
Medical Director
Banner Poison and Drug Information Center
Phoenix
AZ
Declarações
DEB declares that he has no competing interests.
Karl Marlowe, MbChB, MSc, PgC-Ed, PgD-CBT, MRCPsych
Consultant Psychiatrist
East London NHS Foundation Trust
London
UK
Declarações
KM declares that he has no competing interests.
Theodore A. Stern, MD
Chief
Psychiatric Consultation Service
Massachusetts General Hospital
Professor of Psychiatry
Harvard Medical School
Boston
MA
Declarações
TAS declares that he has no competing interests.
Paul M. Gahlinger, MD
Adjunct Professor
Department of Family and Preventive Medicine
University of Utah
Salt Lake City
UT
Declarações
PMG declares that he has no competing interests.
O uso deste conteúdo está sujeito ao nosso aviso legal